File:RNA-Impfstoffe- der schnellste Weg zum Impfschutz gegen SARS-CoV-2-.webm

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

Original file ‎(WebM audio/video file, VP9/Opus, length 54 min 1 s, 1,920 × 1,440 pixels, 830 kbps overall, file size: 320.7 MB)

Captions

Captions

Add a one-line explanation of what this file represents

Summary

[edit]
Description
Deutsch: Dieses Press Briefing fand am 27.04.2020 statt.

Zwei deutsche Biotechnologieunternehmen – CureVac aus Tübingen und BioNTech aus Mainz – beteiligen sich an der klinischen Entwicklung von RNA-Impfstoffen gegen SARS-CoV-2. Das Paul-Ehrlich-Institut hat am 22.04.2020 verkündigt, dass vier RNA-Impfstoffkandidaten der Firma BioNTech nun für klinische Studien an 200 Probanden zugelassen wurden. Welche Impfstoffkandidaten gibt es genau? Was macht die RNA-Impfstoffe so attraktiv? Worin unterscheiden sich die verschiedenen RNA-Impfstoffkandidaten? Warum gibt es noch keinen zugelassenen RNA-Impfstoff? Welche Risiken und Nebenwirkungen wurden bisher in tierexperimentellen Untersuchungen beobachtet, welche könnten beim Menschen auftreten? Brauchen RNA-Impfstoffe Wirkverstärker? Lassen sich RNA-Impfstoffe wirklich schneller in großen Mengen herstellen, wenn alle Welt nach biochemischen Reagenzien fahndet? Diese und weitere Fragen beantworteten Experten bei einem virtuellen Press Briefing.


Hintergrundinformationen finden Sie unter https://www.sciencemediacenter.de/alle-angebote/press-briefing/details/news/rna-impfstoffe-der-schnellste-weg-zum-impfschutz-gegen-sars-cov-2/

Eingeladene Expertinnen und Experten: Prof. Dr. Uğur Şahin Vorstandsvorsitzender BioNTech, Mainz

Dr. Mariola Fotin-Mleczek Chief Technology Officer, CureVac, Tübingen Dr. Mariola Fotin-Mleczek konnte aufgrund technischer Probleme der Veranstaltung leider nicht beitreten.

Prof. Dr. Klaus Cichutek

Präsident des Paul-Ehrlich-Instituts – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel (PEI), Langen
Date
Source YouTube: RNA-Impfstoffe: der schnellste Weg zum Impfschutz gegen SARS-CoV-2? – View/save archived versions on archive.org and archive.today
Author Science Media Center Germany

Licensing

[edit]
This video, screenshot or audio excerpt was originally uploaded on YouTube under a CC license.
Their website states: "YouTube allows users to mark their videos with a Creative Commons CC BY license."
To the uploader: You must provide a link (URL) to the original file and the authorship information if available.
w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 3.0 Unported license.
Attribution: Science Media Center Germany
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
This file, which was originally posted to an external website, has not yet been reviewed by an administrator or reviewer to confirm that the above license is valid. See Category:License review needed for further instructions.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current10:12, 16 June 202254 min 1 s, 1,920 × 1,440 (320.7 MB)PantheraLeo1359531 (talk | contribs)Imported media from https://www.youtube.com/watch?v=lngiJ7F6ums

You cannot overwrite this file.

The following page uses this file:

Transcode status

Update transcode status
Format Bitrate Download Status Encode time
VP9 1440P 1.02 Mbps Completed 14:11, 16 June 2022 3 h 58 min 12 s
Streaming 1440p (VP9) Not ready Error on 20:56, 17 January 2024
VP9 1080P 611 kbps Completed 12:34, 16 June 2022 2 h 21 min 43 s
Streaming 1080p (VP9) Not ready Unknown status
VP9 720P 356 kbps Completed 11:54, 16 June 2022 1 h 41 min 49 s
Streaming 720p (VP9) Not ready Unknown status
VP9 480P 237 kbps Completed 11:18, 16 June 2022 1 h 5 min 43 s
Streaming 480p (VP9) Not ready Unknown status
VP9 360P 175 kbps Completed 11:00, 16 June 2022 47 min 37 s
Streaming 360p (VP9) Not ready Unknown status
VP9 240P 139 kbps Completed 10:46, 16 June 2022 34 min 17 s
Streaming 240p (VP9) 51 kbps Completed 08:06, 16 December 2023 2.0 s
WebM 360P 358 kbps Completed 10:45, 16 June 2022 32 min 59 s
Streaming 144p (MJPEG) 1 Mbps Completed 03:06, 18 November 2023 5 min 29 s
Stereo (Opus) 88 kbps Completed 02:36, 23 November 2023 58 s
Stereo (MP3) 128 kbps Completed 03:02, 18 November 2023 1 min 28 s

Metadata

This file contains additional information such as Exif metadata which may have been added by the digital camera, scanner, or software program used to create or digitize it. If the file has been modified from its original state, some details such as the timestamp may not fully reflect those of the original file. The timestamp is only as accurate as the clock in the camera, and it may be completely wrong.

Retrieved from "https://commons.wikimedia.org/w/index.php?title=File:RNA-Impfstoffe-_der_schnellste_Weg_zum_Impfschutz_gegen_SARS-CoV-2-.webm&oldid=665418065"